NM_032415.7:c.180G>T
Variant names: 
Variant summary
Our verdict is Benign. The variant received -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS1
The NM_032415.7(CARD11):c.180G>T(p.Val60Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00102 in 1,614,146 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
 Genomes: 𝑓 0.00090   (  1   hom.,  cov: 32) 
 Exomes 𝑓:  0.0010   (  0   hom.  ) 
Consequence
 CARD11
NM_032415.7 synonymous
NM_032415.7 synonymous
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  0.290  
Publications
0 publications found 
Genes affected
 CARD11  (HGNC:16393):  (caspase recruitment domain family member 11) The protein encoded by this gene belongs to the membrane-associated guanylate kinase (MAGUK) family, a class of proteins that functions as molecular scaffolds for the assembly of multiprotein complexes at specialized regions of the plasma membrane. This protein is also a member of the CARD protein family, which is defined by carrying a characteristic caspase-associated recruitment domain (CARD). This protein has a domain structure similar to that of CARD14 protein. The CARD domains of both proteins have been shown to specifically interact with BCL10, a protein known to function as a positive regulator of cell apoptosis and NF-kappaB activation. When expressed in cells, this protein activated NF-kappaB and induced the phosphorylation of BCL10. [provided by RefSeq, Jul 2008] 
CARD11 Gene-Disease associations (from GenCC):
- BENTA diseaseInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Orphanet, Ambry Genetics
 - immunodeficiency 11b with atopic dermatitisInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Genomics England PanelApp, Ambry Genetics
 - severe combined immunodeficiency due to CARD11 deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, ClinGen, Orphanet
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.24). 
BP6
Variant 7-2947615-C-A is Benign according to our data. Variant chr7-2947615-C-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 540983.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BP7
Synonymous conserved (PhyloP=0.29 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.0009 (137/152276) while in subpopulation AMR AF = 0.00334 (51/15288). AF 95% confidence interval is 0.00261. There are 1 homozygotes in GnomAd4. There are 70 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| CARD11 | NM_032415.7  | c.180G>T | p.Val60Val | synonymous_variant | Exon 3 of 25 | ENST00000396946.9 | NP_115791.3 | |
| CARD11 | NM_001324281.3  | c.180G>T | p.Val60Val | synonymous_variant | Exon 4 of 26 | NP_001311210.1 | 
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.000907  AC: 138AN: 152158Hom.:  1  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
138
AN: 
152158
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.000891  AC: 224AN: 251472 AF XY:  0.000824   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
224
AN: 
251472
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.00103  AC: 1502AN: 1461870Hom.:  0  Cov.: 31 AF XY:  0.000987  AC XY: 718AN XY: 727236 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
1502
AN: 
1461870
Hom.: 
Cov.: 
31
 AF XY: 
AC XY: 
718
AN XY: 
727236
show subpopulations 
African (AFR) 
 AF: 
AC: 
6
AN: 
33480
American (AMR) 
 AF: 
AC: 
153
AN: 
44724
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
26136
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
39700
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
86258
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
53420
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
5754
European-Non Finnish (NFE) 
 AF: 
AC: 
1261
AN: 
1112002
Other (OTH) 
 AF: 
AC: 
82
AN: 
60396
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.473 
Heterozygous variant carriers
 0 
 81 
 162 
 243 
 324 
 405 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 48 
 96 
 144 
 192 
 240 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome   AF:  0.000900  AC: 137AN: 152276Hom.:  1  Cov.: 32 AF XY:  0.000940  AC XY: 70AN XY: 74446 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
137
AN: 
152276
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
70
AN XY: 
74446
show subpopulations 
African (AFR) 
 AF: 
AC: 
9
AN: 
41564
American (AMR) 
 AF: 
AC: 
51
AN: 
15288
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5180
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
4822
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10604
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
67
AN: 
68026
Other (OTH) 
 AF: 
AC: 
10
AN: 
2116
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.492 
Heterozygous variant carriers
 0 
 10 
 20 
 29 
 39 
 49 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
EpiCase 
 AF: 
EpiControl 
 AF: 
ClinVar
Significance: Benign/Likely benign 
Submissions summary: Benign:4 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not provided    Benign:2 
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Apr 30, 2020
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified    Benign:1 
Jun 08, 2022
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Severe combined immunodeficiency due to CARD11 deficiency;C4551967:BENTA disease    Benign:1 
Jan 26, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.